Items Tagged ‘Stage IV Melanoma’

July 2, 2013

Investigational Melanoma Drug Shrinks Tumors in Phase III Trial

By

In a Phase III clinical trial, the investigational drug T-VEC (talimogene laherparepvec) produced durable responses in people with advanced melanoma.  These results were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO). Of the more than one million new diagnoses of skin cancer each year, roughly 76,000 involve melanoma. More […]

View full entry

Tags: Melanoma, Stage III Melanoma, Stage IV Melanoma


July 1, 2013

Anti-PD-1 Drugs Promising for Advanced Melanoma

By

In Phase I clinical trials, investigational drugs that target a protein known as PD-1 are showing promise for the treatment of advanced melanoma. Results from two of the trials were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology and also published in the New England Journal of Medicine. Of the more […]

View full entry

Tags: Melanoma, Stage III Melanoma, Stage IV Melanoma


June 26, 2013

Selumetinib Active Against Melanoma of the Eye

By

In a Phase II clinical trial, the investigational targeted drug selumetinib resulted in tumor shrinkage in half of patients with advanced melanoma of the eye. These results were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology. Melanoma of the eye—also known as uveal melanoma—is a rare cancer that affects approximately […]

View full entry

Tags: Melanoma, Stage IV Melanoma